These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28346193)

  • 21. Compounding for animal patients: contemporary issues.
    Lust E
    J Am Pharm Assoc (2003); 2004; 44(3):375-84; quiz 384-6. PubMed ID: 15191248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schering-Plough agrees to pay FDA $500 million and bring factories into compliance.
    Kuehn BM
    J Am Vet Med Assoc; 2002 Jul; 221(2):174, 180. PubMed ID: 12118571
    [No Abstract]   [Full Text] [Related]  

  • 23. Viral safety and extraneous agents testing for veterinary vaccines: rationale for requirements, the European approach.
    Bruckner L
    Biologicals; 2010 May; 38(3):338-9. PubMed ID: 20335051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines.
    Allen LV
    Int J Pharm Compd; 2016; 20(4):351. PubMed ID: 28333682
    [No Abstract]   [Full Text] [Related]  

  • 25. Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding.
    Akers MJ
    Int J Pharm Compd; 2016; 20(4):307-314. PubMed ID: 28333676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compounding pharmacies: before and after an inspection.
    Kulkarni D; Ricketts S
    Int J Pharm Compd; 2013; 17(5):358-62. PubMed ID: 24459779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List).
    Int J Pharm Compd; 2016; 20(6):457-458. PubMed ID: 28339383
    [No Abstract]   [Full Text] [Related]  

  • 28. Traditional vs. nontraditional pharmacy.
    Allen LV
    Int J Pharm Compd; 2013; 17(4):351. PubMed ID: 24261152
    [No Abstract]   [Full Text] [Related]  

  • 29. Compounding prokinetic medications for companion animals.
    Gaskins J
    Int J Pharm Compd; 2012; 16(4):276-86. PubMed ID: 23050386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral delivery of medications to companion animals: palatability considerations.
    Thombre AG
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1399-413. PubMed ID: 15191789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extralabel drug use and compounding in veterinary medicine.
    Geyer RE
    Food Drug Law J; 1997; 52(3):291-5. PubMed ID: 10343027
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmaceutical compounding or pharmaceutical manufacturing? A regulatory perspective.
    Timko RJ; Crooker PE
    Int J Pharm Compd; 2014; 18(2):101-11. PubMed ID: 24881112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug compounding for veterinary patients.
    Papich MG
    AAPS J; 2005 Sep; 7(2):E281-7. PubMed ID: 16353910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDA seeks to clear up confusion about compounding.
    J Am Vet Med Assoc; 2003 Oct; 223(8):1103, 1106. PubMed ID: 14584731
    [No Abstract]   [Full Text] [Related]  

  • 35. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Applying Quality by Design Concepts to Pharmacy Compounding.
    Timko RJ
    Int J Pharm Compd; 2015; 19(6):453-63. PubMed ID: 26891559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compounded equine drugs seized from Kentucky pharmacy.
    Kuehn BM
    J Am Vet Med Assoc; 2004 Oct; 225(7):993-4. PubMed ID: 15515973
    [No Abstract]   [Full Text] [Related]  

  • 38. The U.S. Food and Drug Administration responds to the International Academy of Compounding Pharmacists' outsourcing letter.
    Int J Pharm Compd; 2014; 18(3):208. PubMed ID: 25306767
    [No Abstract]   [Full Text] [Related]  

  • 39. Choosing a Vial Processing Line for Aseptic Compounding: Part 1.
    Noorian S; Vahedi N
    Int J Pharm Compd; 2016; 20(4):283-292. PubMed ID: 28333673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IACP's continuing support of compounding pharmacists: letter to the FDA concerning 503B outsourcing facilities.
    Miller DG
    Int J Pharm Compd; 2014; 18(2):117-8. PubMed ID: 24881114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.